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Background: Critical illness constitutes a serious derangement of metabolism. The aim of our study was to
compare acute phase metabolic patterns in children with sepsis (S) or severe sepsis/septic shock (SS) to those with
severe traumatic brain injury (TBI) and healthy controls (C) and to evaluate their relations to neutrophil, lymphocyte
and monocyte expressions of CD64 and CD11b.
Methods: Sixty children were enrolled in the study. Forty-five children with systemic inflammatory response syndrome
(SIRS) were classified into three groups: TBI (n = 15), S (n = 15), and SS (n = 15). C consisted of 15 non- SIRS patients
undergoing screening tests for minor elective surgery. Blood samples were collected within 6 hours after admission for
flow cytometry of neutrophil, lymphocyte and monocyte expression of CD64 and CD11b (n = 60). Procalcitonin (PCT),
C-reactive protein (CRP), glucose, triglycerides (TG), total cholesterol (TC), high (HDL) or low-density-lipoproteins (LDL)
were also determined in all groups, and repeated on day 2 and 3 in the 3 SIRS groups (n = 150).
Results: CRP, PCT and TG (p < 0.01) were significantly increased in S and SS compared to TBI and C; glucose did not differ
among critically ill groups. Significantly lower were the levels of TC, LDL, and HDL in septic groups compared to C and to
moderate changes in TBI (p < 0.0001) but only LDL differed between S and SS (p < 0.02). Among septic patients, PCT
levels declined significantly (p < 0.02) with time, followed by parallel decrease of HDL (p < 0.03) and increase of TG
(p < 0.02) in the SS group. Neutrophil CD64 (nCD64) expression was higher in patients with SS (81.2%) and S (78.8%) as
compared to those with TBI (5.5%) or C (0.9%, p < 0.0001). nCD64 was positively related with CRP, PCT, glucose, and TG
(p < 0.01) and negatively with TC, LDL, and HDL (p < 0.0001), but not with severity of illness, hematologic indices, length
of stay or mechanical ventilation duration.
Conclusions: In sepsis, the early stress-metabolic pattern is characterized by a high (nCD64, glucose, TG) - low (TC, HDL,
LDL) combination in contrast to the moderate pattern of TBI in which only glucose increases combined with a moderate
cholesterol - lipoprotein decrease. These early metabolic patterns persist the first 3 days of acute illness and are associated
with the acute phase CD64 expression on neutrophils.
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Sepsis may be elicited through either pathogen-associated
or danger-associated (in the absence of infection) molecular
patterns (PAMPs or DAMPs, respectively) as a systemic
inflammatory response syndrome (SIRS) [1]. Once primed
by bacterial products and endogenous mediators, neutro-
phils are critical effector cells during acute inflammatory
processes [2]. The CD64 is a membrane glycoprotein that
mediates endocytosis, phagocytosis, antibody-dependent
cellular toxicity, cytokine release, and superoxide gener-
ation. It is constitutively expressed on monocytes and
macrophages. It is expressed at low concentration on the
surface of non-activated neutrophils, but can be markedly
upregulated at the onset of sepsis [3]. Elevated monocyte
CD64 expression was reported in adult patients with sep-
sis [4] and in a mixed group of neonates and children with
SIRS and sepsis [5]. Neutrophil CD64 (nCD64) expression
has been found to be a better diagnostic marker for sepsis
than procalcitonin (PCT) [6] and C-reactive protein (CRP)
[7] in adults and recently in children [8]. An increase in the
expression of integrins of the beta 2 subfamily on neutro-
phils, in particular CD11b, is also considered to be a good
marker of cell activation [9]. Contradictory results regard-
ing neutrophil CD11b expression in premature infants [10]
and adult patients with sepsis [11] and septic shock [9] have
been reported.
Critical illness constitutes a serious derangement of
metabolism, hallmarked by hypometabolism [12], pro-
tein breakdown, hyperglycemia, and an altered serum
lipid profile [13]. It has recently been shown that plasma
levels of lipid peroxidation biomarkers increased signifi-
cantly in the first 70 hours after severe traumatic brain
injury (TBI) [14]. Reductions in mitochondrial energetics
and brain energy stores resulting from TBI may put ex-
treme stress on brain metabolism to maintain these crit-
ical gradients [15]. Systemic inflammation and sepsis are
also accompanied by severe metabolic alterations, includ-
ing insulin resistance together with increased levels of
triglycerides (TG) and decreases in high- (HDL) and low-
density-lipoproteins (LDL) [16]. Total cholesterol (TC),
LDL, HDL, and apolipoproteins were all found to be sig-
nificantly lower in non-survivors than in survivors adult
patients after sepsis criteria had been met for the first time
[17]. Low TC and lipoprotein concentrations found in
critically ill surgical patients correlated with interleukins 6
and 10, soluble interleukin-2 receptor, and predicted
clinical outcome [18]. In vitro as well as in vivo, the
addition of lipoproteins almost abrogated the release of
proinflammatory cytokines [19,20]. We have also shown
that early pharmaco-nutrition might modulate cytokines
in children with septic shock [21] or TBI [22], although it
could not offer clinical advantage over the one demon-
strated by non-immune enhancing enteral nutrition. In
addition, the cytokine response in SIRS or sepsis wasreliably reflected by increases in prognostic inflammatory
and nutritional indices but not by the metabolic patterns
[12]. CRP, however, was shown to promote atherogenesis
through inducing lectin-like oxidized low-density lipopro-
tein receptor-1 an endothelial receptor that plays a pivotal
role in endothelial dysfunction [23].
Cellular membranes contain microdomains known as
‘lipid rafts’ or detergent-insoluble microdomains enriched
in cholesterol and sphingolipids. Among other T cell or B
cell receptors, CD64 have been shown to reside within lipid
rafts without prior triggering of the receptor [24]. CD64
was also shown to co-patch with GM1, a microdomain-
enriched glycolipid, and that depletion of cellular choles-
terol, modulated CD64-ligand interactions [24]. Increased
detergent resistant fraction of membranes-association of
the Fc gamma RI receptor CD64 and the complement
receptor 3 complex CD11b/CD18 were observed from pa-
tients with SIRS/sepsis or coronary artery disease myocar-
dial infarction [25]. Flow cytometry studies using CD16,
CD32 and CD64 monoclonal antibodies showed a sharp
reduction on the expression of CD64 both by human
monocyte-derived macrophages and THP-1 cells after in-
cubation with LDL, suggesting preferential engagement of
this type of Fc receptor [26]. Assessment of early (first 6 -
hours) metabolic patterns in critically ill children with dif-
ferent sepsis severity or severe TBI and their relation to
the main white blood cells (WBC) surface CD64 and
CD11b expressions has not been previously attempted.
Presumed association of sepsis and/or SIRS with an acute
“metabolic syndrome” might open new horizons in the re-
search of early metabolic disturbances in acute stress states,
aiming at studying combined immunological and nutri-
tional interventions in sepsis and other critical illnesses.
This study tests the hypothesis that early stress-metabolic
patterns in children with severe sepsis or TBI (non-infectious
SIRS) differ, compared to the non-stressed metabolism of
healthy children. The study also aims to elucidate whether
the acute stress (first 6 hours) plasma concentrations of
glucose, TG, TC, HDL or LDL are associated with in-
creased CD64 and/or CD11b expression on neutrophils,
monocytes, and lymphocytes in children with sepsis (S)
and severe sepsis/septic shock (SS) as compared to those
with severe TBI or healthy controls (C).
Methods
Patients and setting
This prospective observational study was conducted in the
University Pediatric Intensive Care Unit (PICU) between
January 2010 and June 2011. Forty-five critically ill chil-
dren admitted to the PICU with clinical diagnosis of TBI
associated SIRS (n = 15), S (n = 15), and SS (n = 15) were
enrolled in the study within 6 hours of admission. Fifteen
healthy children undergoing screening tests for minor
elective surgery were used as the control group. Allocation
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of flow cytometry, attending physician until 15 children
were included in each group. Although only 3 of the se-
vere sepsis group presented with septic shock, all severe
sepsis and septic shock patients had SIRS, infection and
more the 2 organ system failures, thereby representing the
homogenous SS group. Our trauma patients were TBI
with severe head injury and almost all had additional
minor non-life threatening injuries (lung contusions, frac-
tures, liver or spleen lacerations). Patients’ characteristics
and outcome endpoints, as are the length of stay (LOS)
and length of mechanical ventilation (LOMV), are sum-
marized in Table 1. Patients were on standard glucose so-
lutions with electrolytes during the first 6–12 hours upon
admission. After initial blood studies, all patients were put
on isocaloric - isonitrogenous enteral nutrition. None of the
patients received parenteral nutrition. The Pediatric Risk of
Mortality Score (PRISM) [27], the Therapeutic Intervention
Scoring System (TISS) modified for children [28], and the
Pediatric Logistic Organ Dysfunction Score (PELOD) were
calculated as markers of severity of disease on the day of
blood sampling [29]. Sepsis, severe sepsis, septic shock, and
SIRS due to traumatic brain injury were defined according
to the International Pediatric Sepsis Consensus Conference
definitions [30]. Thirty-seven patients with malignancies,
metabolic or endocrine diseases (diabetes, hypercholesterol-
emia) or immune-compromised (immunosuppressive agents
but not stress-dose hydrocortisone) were excluded.
Admission blood and urine cultures, bronchoalveolar
lavage (BAL), and pharyngeal and deep tissue swabs were
taken in all critically ill patients, although most of our pa-
tients had already been on antibiotics prior to their admis-
sion to the PICU. All traumatic brain injury patients had
severe head injury (Glasgow Coma Scale (GCS) between 5
and 9, with continuous intracranial pressure monitoring).Table 1 Characteristics of the study population
Control TBI
Number 15 15
Gender Male/Female 11/4 9/6
Age [years] 8 (2–14) 7.5 (2–15)
Mortality 0 2
PRISM II NA 9.5 (6–29)
PELOD NA 2.5 (1–21) b
TISS NA 41 (26–57)
LOS [days] NA 7 (3–18) b
LOMV [days] NA 5 (2–14) b
Results are given as Median (range).
a Statistically significant differences, Kruskal-Wallis test.
b, cPost-hoc Mann–Whitney U-test between 2 groups (p < 0.03).
TBI, Traumatic Brain Injury; PRISM, Pediatric Risk of Mortality; TISS, the Therapeutic I
Length Of Stay; LOMV, Length Of Mechanical Ventilation.CD64 and CD11b expression assays-flow cytometry
Blood was drawn for routine exams at the time of admis-
sion. Venous blood was processed to measure WBC, PCT,
and CRP levels. Whole blood EDTA-anticoagulated sam-
ples were immediately transported to the laboratory for
flow cytometric CD11b and CD64 analysis. More specific-
ally 100 μl of the whole blood sample were incubated with
both fluoroscein isothiocyanate (FITC) - conjugated CD11b
(Clone Bear1) and R- Phycoerythrin (PE) - conjugated
CD64 (Clone 22) for 20 min, in the dark, at room
temperature. FITC and PE –mouse IgG was used as isotype
control (antibodies from IMMUNOTECH- BECKMAN
COULTER, Marseille, France). Labeled cells were
thoroughly washed with PBS + 2% FCS + 0.05% Sodium
Azide. Following lysis in Immunoprep Reagent System
(BECKMAN COULTER, Mervue, Galway, Ireland) they
were analyzed on an Epics-Coulter cytometer. Cells were
initially gated according to their morphology (side- and
forward-scatter characteristics) and more than 30000 cells
were acquired in each sample. Results are presented as the
percentage (%) of positive-staining cells. Analysis was
performed in lymphocytes, monocytes and polymorpho-
nuclear cells.
Routine laboratory measurements
CRP assays were performed on the Dade Behring BN
II immunonephelometer (Dade Behring Diagnostics Inc.,
Somerville, NJ). CRP levels >0.8 mg/dL were considered ab-
normal. PCT was measured by an immunoluminometric
assay (Lumitest-PCT, Brahms-Diagnostica, Berlin, Germany).
Detection threshold was 0.1 ng/mL; PCT levels >0.5 ng/mL
were considered abnormal (Laboratory cut off values).
Plasma concentrations of glucose, TG, TC, HDL or LDL,
and hematological markers were measured by routine la-
boratory methods. All nutritional indices and acute phaseSepsis Severe sepsis p value
15 15
8/7 9/6 0.3
3.75 (1–18) 7 (1–14) 0.26
0 0 0.09
11 (2–20) 16 (6–26) 0.06
2 (1–13) c 14 (10–32) b, c 0.006 a
36.5 (25–47) 44 (32–49) 0.3
10.5 (3–98) 21 (6–235) b 0.02 a
6 (0–95) 15 (0–235) b 0.13
ntervention Scoring System; PELOD, Paediatric Logistic Organ Dysfunction; LOS,
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SS and TBI groups (n = 150 including day 1 group C).
Research ethics
The study was approved by the Ethical Committee of the
University Hospital, Heraklion. Written informed consent
was obtained from the parents before inclusion in this
study. All data were anonymous.
Statistical analysis
The one-sample Kolmogorov–Smirnoff test was used to
determine the distribution of data from measured parame-
ters. Data are presented as the median and range. Group
comparisons were performed by using the Kruskal-Wallis
test. The variables that showed differences among the 4
groups were compared group-by-group applying the
Mann–Whitney test. Friedman’s two-way analysis of vari-
ance by ranks for non-parametric related-samples was used
for comparing the 3-day-series measurements. The correl-
ation between variables was analyzed by the Spearman cor-
relation test. Proportions of patients were compared by the
χ2 test. A two-sided alpha of 0.05 was used for statistical
significance. The results were analyzed using SPSS software
(version 20.0, SPSS, Chicago, Ill).
Results
There were no statistical differences regarding gender and
age in the studied groups. Only 2 patients in the TBI group
died, both having suffered multiple injuries from motor ve-
hicle accidents (patients with the highest PRISM and TISS).
Patients with severe sepsis had higher severity scores and
longer stay in PICU or duration of mechanical ventilation




CRP (mg/dl) 0.3 (0.1-0.7) b,c,d 0.3 (0.3-11) c,e,f
PCT (ng/ml) 0.2 (0.1-0.4) b,c,d 0.5 (0.1-2) c,e,f
WBC 9.7 (8.4-11) 12.3 (4.4-28)
Platelets (K/μl) 256 (212–300) 288 (135–518)
Glucose (mg/dl) 83 (74–108) b,c,d 134 (71–243) c
TG (mg/dl) 71.8 (33–150) b,d 79.2 (27–175) e,f
TC (mg/dl) 171.3 (133–235) b,c,d 132 (98–166) c, f
LDL (mg/dl) 98.1 (57–155) b,c,d 72.2 (41–110) c f
HDL (mg/dl) 58.7 (45–76) b,c,d 45.3 (24–62) c,e f
TC/HDL (ratio) 2.9 (2.3-3.8) b,d 3.1 (2.1-5.2) c f
Results are given as Median (range).
a Statistically significant differences, Kruskal-Wallis test.
b –g Post-hoc Mann–Whitney U-test between 2 groups (p < 0.05).
SIRS, systemic inflammatory response syndrome; TBI, Traumatic Brain Injury; CRP, C-
LDL, Low-Density-Lipoproteins; HDL-Density-Lipoproteins; WBC, White Blood Cells.In the two septic groups, pathogens isolated were as fol-
lows: blood: Streptococcus pneumoniae (n = 2), Staphylo-
coccus haemolyticus (n = 2), Neisseria meningitidis (n = 1),
Acinetobacter baumannii (n = 2), and Candida species
(n = 1); BAL: Pseudomonas aeruginosa (n = 4), Serratia
marcescens (n = 1), Stenotrophomonas maltophilia (n = 2),
and Candida species (n = 5); urine: Pseudomonas
aeruginosa (n = 2); central nervous system: Neisseria
meningitidis (n = 1). Patients without isolates had received
antibiotics before PICU admission. No pathogens were
isolated from the blood and samples from other sites in
TBI patients.
WBCs and platelets did not differ among groups. Al-
though glucose levels were not different among septic
and TBI groups, patients of each of the 3 critically ill
groups had significantly increased glucose levels compared
to controls. Admission levels of CRP, PCT, TG and the TC/
HDL ratio were significantly increased in S and SS com-
pared to TBI and C groups (Table 2). Significantly lower
were the levels of TC, LDL, and HDL in septic groups com-
pared to C and even to TBI (moderately decreased levels).
However, only LDL could discriminate between the two
septic groups (p < 0.02) (Figure 1). Although 2 patients with
candidemia had low PCT and/or CRP levels (outliers), des-
pite high CD64 expression, differences between bacterial
and candida septic patients did not reach statistical signifi-
cance in any of the measured indices.
Glucose, TC, and LDL levels did not differ among days
1, 2 or 3 in any of the SIRS groups (Figure 2). Among
septic patients, first 3 days PCT levels declined signifi-
cantly (p < 0.02), followed by parallel decreases of HDL
(p < 0.03) and increases of TG (p < 0.02) in the SS group.
CRP changes in TBI and S groups were not reflected byolic indices in children with SIRS compared to healthy
Sepsis Severe sepsis p value
edians (ranges)
6.4 (0.5-15) d,e 12.8 (3.1-41) b,f 0.0001a
8 (0.3-12) d,e 11.5 (0.3-12) b,f 0.0001a
20.8 (2–43) 9.9 (1.5-47) 0.31
285 (105–801) 215 (24–451) 0.33
115 (65–202) d 118 (77–153) b 0.002a
151.7 (80–326) d,e 209.1 (34–591) b,f 0.007a
125.2 (56–208) d 100.6 (45–150) b, f 0.0001a
66.2 (15–111) d,g 33.4 (13–63) b,f,g 0.0001a
27.3 (12–57) d,e 29.5 9–62) b,f 0.0001a
5.0 (3–8.7) d,c 5.5 (2.67-12.1) b,f 0.05a
Reacting Protein; PCT, Procalcitonin; TG, Triglycerides; TC, Total Cholesterol;
Figure 1 Early phase metabolic patterns were characteristic of the pathologic process significantly differing between sepsis and TBI.
Box plots of a) glucose (GL), b) triglycerides (TG), c) low-density-lipoproteins (LDL), and d) high-density-lipoproteins (HDL) in healthy children and in
patients with systemic inflammatory response syndrome (SIRS) after Traumatic Brain Injury (TBI), sepsis (S), or severe sepsis (SS). Metabolic patterns differed
among the four groups: TG levels were significantly increased and TC, LDL, and HDL significantly lower in septic compared to C and/or TBI groups (p <
0.01)*. GL did not differ between TBI and sepsis groups, whereas only LDL differed between S and SS (p < 0.02)**. The bold black line in box plots indicates
the median per group, the bottom of the box indicates the 25th percentile and the top of the box represents the 75th percentile; the T-bars (whiskers)
and horizontal lines show minimum and maximum values of the calculated non-outlier values.
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All 3 days PCT and CRP differed between TBI and SS
(p < 0.005) but only PCR differed between S and SS on
days 2 and 3 (p <0. 001). All 3 days HDL and TG differed
between S or SS and TBI (p < 0.04); LDL day 2 was lower
in SS compared to TBI (p < 0.03).
There was no difference in the neutrophil and monocyte
CD11b expression among groups in all 4 groups studied.
Lymphocyte CD11b showed a trend for lower values in SS
compared to C and TBI or S (Table 3). Admission mono-
cyte CD64 did not vary among groups. Lymphocyte CD64
was found extremely low as expected. Although admission
neutrophil CD64 expression did not differ between the two
septic groups it was significantly higher in patients with SS
or S as compared to TBI and C (Table 3).Neutrophil CD64 expression differences were not
influenced by WBC or neutrophil population varia-
tions among groups, rather paralleling a similar incre-
mental stress-response of acute phase proteins
(Figure 3). Neutrophil CD64 was positively related
with serum levels of CRP (rs = 0.82 p < 0.0001), PCT
(rs = 0.89, p < 0.0001), glucose (rs = 0.42, p < 0.01), and
TG (rs = 0.46, p < 0.008) and negatively with TC (rs = −0.60,
p < 0.0001), LDL (rs = −0.62, p < 0.0001), and HDL
(rs = −0.70, p < 0.0001). CD64 did not correlate with
any of the severity of illness scoring systems, GCS,
hematologic indices, LOS or LOMV. No correlation
was shown between neutrophil CD11b and any of the se-
verity of illness, acute phase, and metabolic or hematologic
indices.
Figure 2 Early lipid disturbances persisted for3-days in both, the septic and the traumatic metabolic pattern. First 3 days distribution of
a) C-reactive protein (CRP), b) procalcitonin (PCT), c) glucose (GL), d) triglycerides (TG), e) low- (LDL) and f) high-density-lipoproteins (HDL) in
healthy children and in patients with systemic inflammatory response syndrome (SIRS) after Traumatic Brain Injury (TBI), sepsis (S), or severe sepsis
(SS). The 3-day follow up showed a significant longitudinal decrease of PCT in septic patients followed by parallel decreases of HDL and increases
of TG in the SS group. CRP changes in TBI and S groups were not reflected by similar changes in any of the metabolic indices (differences shown
by horizontal lines). Pathologic metabolic patterns were distinct in the sepsis and TBI groups compared to controls and all early (first 6-hours)
HDL and TG differences between S or SS and TBI persisted throughout the first 3 days (p < 0.04); LDL day 2 was lower in SS compared to TBI (p
< 0.03). All 3 days PCT and CRP differed between TBI and SS (p < 0.005); PCT, but not CRP, differed between TBI and S on day 2; in contrast, only
PCR differed between S and SS on days 2 and 3 (p <0. 001).
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We showed that the nCD64 expression associated with
an acute phase metabolic response pattern in severe TBI
is different from the one of early sepsis, whose rapid dis-
turbance is evident upon admission. The highglucose – TG –
lowTC - LDL –HDL stress metabolic pattern of early
septic groups differs from the moderate glucose–
moderate TC - LDL – HDL stress pattern of severe TBI-
related SIRS. We showed that metabolism is disturbed early
(within 6 hours) and differently in SIRS groups (infectious
and non-infectious) compared to the normal metabolic pat-
tern of healthy individuals. We also showed that early
metabolic patterns persist during of acute illness, showing
the same first 3 days TG, HDL and first 2 days LDL differ-
ences among groups. In addition, acute phase PCT, but not
CRP levels, decline steadily in the SS group followed byparallel decrease of HDL and increase of TG. The decreases
in PCT levels but not in CRP levels during the three days is
probably due to the different kinetics of both biomarkers.
However, neutrophil only, but not lymphocyte or mono-
cyte, CD64 expression is higher in septic children as com-
pared to those with TBI or C. Finally we showed that
admission CD11b expression on neutrophils and mono-
cytes is not diagnostic and non-related to the metabolic
patterns, although its expression on lymphocytes may be
suppressed in the presence of severe sepsis.
These results are comparable to those of previous studies
in adults [4,31], children [8], or neonates [32], which have
shown that nCD64 expression was higher in patients with
bacterial SIRS compared to non-bacterial SIRS [33]. It is
the first time, though, that all 3 cell lines’ CD64 expression
were simultaneously examined in children with TBI and
Table 3 Admission CD11b and CD64 (%) for neutrophils, monocytes, and lymphocytes in 3 groups of critically ill
children compared to healthy controls
Control TBI Sepsis Severe sepsis p value
Values are medians (ranges)
Neutrophils
CD11b (%) 99.6 (98–100) 98.9 (93–100) 99 (92.6-99.9) 99.6 (96.3-100) 0.29
CD64 (%) 0.9 (0.1-4.3) b,c,d 5.5 (3–11.3) c,e,f 78.8 (25.7-97.3) b,e 81.2 (17.5-97.8) d,f 0.0001a
Monocytes
CD11b (%) 96 (86–99) 96.4 (92–99) 95 (52–99) 87.4 (24–97) 0.11
CD64 (%) 87.4 (78–94) 87.9 (87–97) 90.9 (42–99) 87.3 (18–94) 0.52
Lymphocytes
CD11b (%) 22.9 (7.7-36.5) 18.3 (8.2-39.5) 16.8 (7.3-42) 9.3 (0.9-33.5) 0.043a
CD64 (%) 0.1 (0–2.6) b,c 0.6 (0.1-3.8) c 0.82 (0.3-1.5) b 0.25 (0.1-2.9) 0.01a
Results are given as Median (range).
a Statistically significant differences, Kruskal-Wallis test.
b –f Post-hoc Mann–Whitney U-test between 2 groups (p < 0.03).
TBI, Traumatic Brain Injury.
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nCD64 expression has been thought to increase with sepsis
severity [34], we did not find nCD64 expression to be
influenced by severity of illness or even sepsis staging, but
by the presence of “sepsis” itself. In our TBI group, CD64
and CD11b were not related to GCS or any of the severity
scoring, acute phase, or hematologic indices. We did not
find any relation between CD64 and CD11b in all four
groups studied; however, during sepsis, cell surface antigen
functionality may be expressed independently. This is fur-
ther supported by recent work showing that CD64 was
upregulated, CD16 downregulated, and CD32 remained
unchanged during sepsis [35]. In support to our results, no
differences were found in CD11b expression on neutrophils
and monocytes among adult healthy volunteers, patients
with sepsis, severe sepsis and septic shock [36]. It is not
therefore surprising, that none of the 3 cell lines expressing
CD11b in our series could differentiate critically children in
stress from healthy controls. Nonetheless, if it has been
technically possible to follow CD64 and CD11b levels dur-
ing the first admission days, their evolution could have
probably offered higher accuracy.
Although the CD64 index was shown to be specific for
bacterial infection among ICU patients, its weak sensi-
tivity demanded its combination with a more sensitive
biological marker [37]. This is the first time that the
CD11b integrins and the CD64 high-affinity receptors
expressed on lymphocytes, monocytes, and neutrophils
are related to metabolic patterns in critically ill patients.
In contrast to the critically ill adult patients, in which no
significant differences in TG were found between infec-
tious and non-infectious disease patients [38], we showed
an early glucose-TG increase in both sepsis groups in con-
trast to the hyperglycemia only TBI pattern. These differ-
ent metabolic patterns were characterized by an earlysignificant decrease of TC, HDL, LDL in the septic groups
compared to moderate cholesterol - lipoprotein decrease
of TBI and the normal levels of C groups. In an observa-
tion study in adults, low HDL also pointed to bacterial in-
fection and low TC was predictive of adverse outcomes in
patients with lower respiratory tract infections [39]. Our
results confirm findings of a recent adult study, showing
that the levels of TC, LDL, and HDL were highly signifi-
cantly lower than in controls, especially in the most se-
verely affected septic groups [40]. Although rapid decline
was primarily described in the HDL, suggesting a decline in
lipoprotein particles [41], we found a rapid (within 6 hours)
decline in both HDL and LDL fractions and also in TC ac-
companied by early increase in glucose, TG associated with
increased nCD64 expression. We showed for the first time
that the TC/HDL ratio, a robust measure of cardiovascular
disease risk [42,43], is steadily increased in the context of
acute stress in children with sepsis or severe TBI. We also
showed that the steadily declining acute phase PCT levels
in the SS group were followed by parallel decreases of
HDL and increases of TG; importantly, only LDL differed
between S and SS groups. The clinical importance of these
results however should be further evaluated in larger mul-
ticenter studies.
A strong positive relation between nCD64 and TG or
glucose and a negative one with TC, HDL, and LDL may
suggest a direct rapid effect of the inflammatory process
on metabolism. It is possible that triglycerides rapidly re-
spond in sepsis in an effort to protect from endotoxin,
since lipoprotein- lipopolysaccharide (LPS) binding is as-
sociated with an attenuated response to this toxic
macromolecule [44]. Approximately 80% of the LPS
was bound to lipoproteins after preincubation with ei-
ther fasting or hypertriglyceridemic blood; in addition,
hypertriglyceridemic but not fasting blood inhibited the
Figure 3 Neutrophil CD64 expression responded to acute stress not to white blood cell or neutrophil activation. Box plots of a) White
blood cells (WBC) and Neutrophils, b) C-reactive protein (CRP), c) procalcitonin (PCT), and d) Fc gamma receptor expression on neutrophils
(nCD64) in healthy children and in patients with systemic inflammatory response syndrome (SIRS) after Traumatic Brain Injury (TBI), sepsis (S), or
severe sepsis (SS). CRP and PCT differed between the septic groups and C (p < 0.001)* and/or TBI groups (p < 0.03)#. In contrast to the WBC and
neutrophils, which did not differ among groups, nCD64 differed between septic groups and C or TBI groups (p < 0.001)* and between TBI and C
groups (p < 0.02)**. The bold black line in box plots indicates the median per group, the bottom of the box indicates the 25th percentile and the
top of the box represents the 75th percentile; the TBI-bars (whiskers) and horizontal lines show minimum and maximum values of the calculated
non-outlier values.
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LPS [44]. Similarly, a multivariate logistic regression ana-
lysis, corrected for baseline univariate risk factors and the
effect on inflammation, indicated that lipid rather than glu-
cose control independently determined the beneficial ef-
fects of intensive insulin therapy on morbidity and
mortality [45]. The different metabolic patterns we noted
also point to the importance of TG metabolism rather
(high in S and SS only) than the one of glucose (similar
in all SIRS groups). Thus, although early hyperglycemia
in TBI has been linked to increased catecholamine con-
centrations and lower GCS score [46], we did not find
any association of admission glucose levels to the severity
scoring systems or acute phase proteins. However, ourfinding of low TC not only in sepsis but also in TBI was
further supported by results of a recent study showing sub-
stantial hypocholesterolemia in TBI greater with shock but
less with brain injury [47].
It has been recently reported that 62% of hyperglycemic
septic children had overt insulin resistance on admission
and 17% had β-cell dysfunction [48] and that the endotoxin
activity was significantly associated with 52% increased risk
for incident diabetes [49]. Further studies are needed to
examine the cross talk between hormonal and inflamma-
tory responses in the development of SIRS in sepsis, since
the metabolic and immune systems are closely involved in
inflammation and may significantly contribute to the crit-
ically illness pathology [1]. Although limited by the small
Fitrolaki et al. BMC Pediatrics 2013, 13:31 Page 9 of 10
http://www.biomedcentral.com/1471-2431/13/31sample size, our study might contribute in setting up the
stage for larger cohort of patients; the precise role of these
molecules and their possible implications in the manipula-
tion of the metabolic disturbances should be further ex-
amined and provide new data for the management of
sepsis and possible nutritional and therapeutic targets for
the critically ill.Conclusions
Acute-phase stress-metabolic pattern in traumatic brain in-
jury, thereof a non-infectious SIRS, is different from the
one of sepsis, whose response is evident within 6 hours of
admission associated with increased acute phase proteins.
The early sepsis stress-metabolic pattern is characterized by
a high (nCD64, glucose, TG) - low (TC, HDL, LDL) com-
bination in contrast to the TBI in which with the exception
of an increased glucose, lipoprotein decrease is moderate
and nCD64 or TG increases are not evident. Importantly,
early metabolic patterns persist during the first 3 days of
acute phase of sepsis or TBI. Early neutrophil, but not
lymphocyte or monocyte, CD64 expression differentiates
children with sepsis from those with trauma and is associ-
ated with high CRP, PCT.Key messages
 Metabolism is early and differently disturbed in
infectious and non-infectious SIRS in critically ill
children
 In sepsis, the early stress-metabolic pattern is
characterized by a high (nCD64, glucose, TG) - low
(TC, HDL, LDL) combination
 TBI early stress-metabolic pattern is moderate,
combining glucose increase with moderate
cholesterol - lipoprotein decrease
 Early stress-metabolic patterns are associated with
the acute phase CD64 expression on neutrophils,
but not on lymphocytes or monocytes or with the
CD11b expression
 Early acute phase stress-metabolic patterns of sepsis
and TBI persist the first 3 days of acute illness
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